Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience

2012 ◽  
Vol 7 (11) ◽  
pp. 1275-1284 ◽  
Author(s):  
Azeem Latib ◽  
Alfonso Ielasi ◽  
Matteo Montorfano ◽  
Francesco Maisano ◽  
Alaide Chieffo ◽  
...  
Authorea ◽  
2020 ◽  
Author(s):  
Bilge Duran Karaduman ◽  
H seyin Ayhan ◽  
Serkan Bulguro lu ◽  
Telat Keles ◽  
Engin Bozkurt

2020 ◽  
Vol 35 (12) ◽  
pp. 3592-3595
Author(s):  
Bilge Duran Karaduman ◽  
Hüseyin Ayhan ◽  
Serkan Bulguroğlu ◽  
Telat Keleş ◽  
Engin Bozkurt

2014 ◽  
Vol 41 (5) ◽  
pp. 507-510 ◽  
Author(s):  
Ali Mortazavi ◽  
Ross M. Reul ◽  
Leon Cannizzaro ◽  
Kathryn G. Dougherty

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.


2017 ◽  
Vol 12 (01) ◽  
pp. 40 ◽  
Author(s):  
Ren Jie Yao ◽  
Matheus Simonato ◽  
Danny Dvir ◽  
◽  
◽  
...  

Bioprosthetic surgical valves are increasingly implanted during cardiac surgery, instead of mechanical valves. These tissue valves are associated with limited durability and as a result transcatheter valve-in-valve procedures are performed to treat failed bioprostheses. A relatively common adverse event of aortic valve-in-valve procedures is residual stenosis. Larger surgical valve size, supra-annular transcatheter heart valve type, as well as higher transcatheter heart valve implantation depth, have all been shown to reduce the incidence of elevated post-procedural gradients. With greater understanding of technical considerations and surgical planning, valve-invalve procedures could be more effective and eventually may become the standard of care for our increasingly ageing and comorbid population with failed surgical bioprostheses.


2015 ◽  
Vol 31 (6) ◽  
pp. 819.e9-819.e11 ◽  
Author(s):  
Jean-Michel Paradis ◽  
Mathieu Bernier ◽  
Christine Houde ◽  
Éric Dumont ◽  
Daniel Doyle ◽  
...  

2015 ◽  
Vol 16 (2) ◽  
pp. 96 ◽  
Author(s):  
Ziv Beckerman ◽  
Oved Cohen ◽  
Arthur Kerner ◽  
Ariel Roguin ◽  
Avishai Ziser ◽  
...  

The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.


Sign in / Sign up

Export Citation Format

Share Document